Distinct inflammation-related proteins associated with T cell immune recovery during chronic HIV-1 infection

References

• Hayes RJ, Donnell D, Floyd S, et al. Effect of universal testing and treatment on HIV incidence – HPTN 071 (PopART). N Engl J Med. 2019 Jul 18;381(3):207–218. DOI:10.1056/NEJMoa1814556.
   PubMed Web of Science ®Google Scholar
• Yang X, Su B, Zhang X, et al. Incomplete immune reconstitution in HIV/AIDS patients on antiretroviral therapy: challenges of immunological non-responders. J Leukoc Biol. 2020 Apr;107(4):597–612. DOI:10.1002/JLB.4MR1019-189R.
   PubMed Web of Science ®Google Scholar
• Farahani M, Mulinder H, Farahani A, et al. Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: a systematic review and meta-analysis. Int J STD AIDS. 2017 Jun;28(7):636–650. DOI:10.1177/0956462416632428.
   PubMed Web of Science ®Google Scholar
• Weber R, Ruppik M, Rickenbach M, et al. Decreasing mortality and changing patterns of causes of death in the Swiss HIV cohort study. HIV Med. 2013 Apr;14(4):195–207. DOI:10.1111/j.1468-1293.2012.01051.x.
   PubMed Web of Science ®Google Scholar
• Ahn MY, Jiamsakul A, Khusuwan S, et al. The influence of age-associated comorbidities on responses to combination antiretroviral therapy in older people living with HIV. J Int AIDS Soc. 2019 Feb;22(2):e25228. DOI:10.1002/jia2.25228.
   PubMed Web of Science ®Google Scholar
• Roul H, Mary-Krause M, Ghosn J, et al. CD4 + cell count recovery after combined antiretroviral therapy in the modern combined antiretroviral therapy era. AIDS. 2018 Nov 13;32(17):2605–2614. DOI:10.1097/QAD.0000000000002010.
   PubMed Web of Science ®Google Scholar
• Marcus JL, Leyden WA, Chao CR, et al. Differences in response to antiretroviral therapy by Sex and hepatitis C infection status. AIDS Patient Care STDS. 2015 Jul;29(7):370–8. DOI:10.1089/apc.2015.0040.
   PubMed Web of Science ®Google Scholar
• Liu J, Wang L, Hou Y, et al. Immune restoration in HIV-1-infected patients after 12 years of antiretroviral therapy: a real-world observational study. Emerg Microbes Infect. 2020 Dec;9(1):2550–2561. DOI:10.1080/22221751.2020.1840928.
   PubMed Web of Science ®Google Scholar
• Tenorio AR, Zheng Y, Bosch RJ, et al. Soluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatment. J Infect Dis. 2014 Oct 15;210(8):1248–59. DOI:10.1093/infdis/jiu254.
   PubMed Web of Science ®Google Scholar
• Angelidou K, Hunt PW, Landay AL, et al. Changes in inflammation but Not in T-cell activation precede Non-AIDS-defining events in a case-control study of patients on long-term antiretroviral therapy. J Infect Dis. 2018 Jun 20;218(2):239–248. DOI:10.1093/infdis/jix666.
   PubMed Web of Science ®Google Scholar
• Liang H, Duan Z, Li D, et al. Higher levels of circulating monocyte-platelet aggregates are correlated with viremia and increased sCD163 levels in HIV-1 infection. Cell Mol Immunol. 2015 Jul;12(4):435–43. DOI:10.1038/cmi.2014.66.
   PubMed Web of Science ®Google Scholar
• Liovat AS, Rey-Cuille MA, Lecuroux C, et al. Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection. PLoS One. 2012;7(10):e46143. DOI:10.1371/journal.pone.0046143.
   PubMed Web of Science ®Google Scholar
• Knudsen TB, Ertner G, Petersen J, et al. Plasma soluble CD163 level independently predicts All-cause mortality in HIV-1-infected individuals. J Infect Dis. 2016 Oct 15;214(8):1198–204. DOI:10.1093/infdis/jiw263.
   PubMed Web of Science ®Google Scholar
• Sandler NG, Wand H, Roque A, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011 Mar 15;203(6):780–90. DOI:10.1093/infdis/jiq118.
   PubMed Web of Science ®Google Scholar
• Kuller LH, Tracy R, Belloso W, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008 Oct 21;5(10):e203. DOI:10.1371/journal.pmed.0050203.
   PubMed Web of Science ®Google Scholar
• Lederman MM, Calabrese L, Funderburg NT, et al. Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells. J Infect Dis. 2011 Oct 15;204(8):1217–26. DOI:10.1093/infdis/jir507.
   PubMed Web of Science ®Google Scholar
• Deeks SG, Tracy R, Douek DC. Systemic effects of inflammation on health during chronic HIV infection. Immunity. 2013 Oct 17;39(4):633–45. DOI:10.1016/j.immuni.2013.10.001.
   PubMed Web of Science ®Google Scholar
• Freeman ML, Shive CL, Nguyen TP, et al. Cytokines and T-cell homeostasis in HIV infection. J Infect Dis. 2016 Oct 1;214(Suppl. 2):S51–7. DOI:10.1093/infdis/jiw287.
   PubMedGoogle Scholar
• Schluns KS, Kieper WC, Jameson SC, et al. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol. 2000 Nov;1(5):426–32. DOI:10.1038/80868.
   PubMed Web of Science ®Google Scholar
• Verbist KC, Klonowski KD. Functions of IL-15 in anti-viral immunity: multiplicity and variety. Cytokine. 2012 Sep;59(3):467–78. DOI:10.1016/j.cyto.2012.05.020.
   PubMed Web of Science ®Google Scholar
• Wildbaum G, Netzer N, Karin N. Plasmid DNA encoding IFN-gamma-inducible protein 10 redirects antigen-specific T cell polarization and suppresses experimental autoimmune encephalomyelitis. J Immunol. 2002 Jun 1;168(11):5885–92. DOI:10.4049/jimmunol.168.11.5885.
   PubMed Web of Science ®Google Scholar
• Noel N, Boufassa F, Lecuroux C, et al. Elevated IP10 levels are associated with immune activation and low CD4(+) T-cell counts in HIV controller patients. AIDS. 2014 Feb 20;28(4):467–76. DOI:10.1097/QAD.0000000000000174.
   PubMed Web of Science ®Google Scholar
• Song JW, Zhang C, Fan X, et al. Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nat Commun. 2020 Jul 8;11(1):3410. DOI:10.1038/s41467-020-17240-2.
   PubMed Web of Science ®Google Scholar
• Luo Z, Health SL, Li M, et al. Variation in blood microbial lipopolysaccharide (LPS) contributes to immune reconstitution in response to suppressive antiretroviral therapy in HIV. EBioMedicine. 2022 Jun;80:104037.
   PubMed Web of Science ®Google Scholar
• Vassallo M, Mercie P, Cottalorda J, et al. The role of lipopolysaccharide as a marker of immune activation in HIV-1 infected patients: a systematic literature review. Virol J. 2012 Aug 27;9:174.
   PubMed Web of Science ®Google Scholar
• Saule P, Trauet J, Dutriez V, et al. Accumulation of memory T cells from childhood to old age: central and effector memory cells in CD4(+) versus effector memory and terminally differentiated memory cells in CD8(+) compartment. Mech Ageing Dev. 2006 Mar;127(3):274–81. DOI:10.1016/j.mad.2005.11.001.
   PubMed Web of Science ®Google Scholar
• Kumar BV, Connors TJ, Farber DL. Human T Cell Development, Localization, And function throughout life. Immunity. 2018 Feb 20;48(2):202–213. DOI:10.1016/j.immuni.2018.01.007.
   PubMed Web of Science ®Google Scholar
• Wang XM, Zhang JY, Xing X, et al. Global transcriptomic characterization of T cells in individuals with chronic HIV-1 infection. Cell Discov. 2022 Mar 28;8(1):29. DOI:10.1038/s41421-021-00367-x.
   PubMed Web of Science ®Google Scholar
• Shive CL, Freeman ML, Younes SA, et al. Markers of T cell exhaustion and senescence and their relationship to plasma TGF-beta levels in treated HIV+ immune Non-responders. Front Immunol. 2021;12:638010.
   PubMed Web of Science ®Google Scholar
• Carvalho-Silva WHV, Andrade-Santos JL, Souto FO, et al. Immunological recovery failure in cART-treated HIV-positive patients is associated with reduced thymic output and RTE CD4+ T cell death by pyroptosis. J Leukoc Biol. 2020 Jan;107(1):85–94. DOI:10.1002/JLB.4A0919-235R.
   PubMed Web of Science ®Google Scholar
• Pino M, Pereira Ribeiro S, Pagliuzza A, et al. Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ART. PLoS Pathog. 2021 Aug;17(8):e1009825. DOI:10.1371/journal.ppat.1009825.
   PubMed Web of Science ®Google Scholar
• Li T, Wu N, Dai Y, et al. Reduced thymic output is a major mechanism of immune reconstitution failure in HIV-infected patients after long-term antiretroviral therapy. Clin Infect Dis. 2011 Nov;53(9):944–51. DOI:10.1093/cid/cir552.
   PubMed Web of Science ®Google Scholar
• Brenchley JM, Price DA, Schacker TW, et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med. 2006 Dec;12(12):1365–71. DOI:10.1038/nm1511.
   PubMed Web of Science ®Google Scholar
• Marchetti G, Tincati C, Silvestri G. Microbial translocation in the pathogenesis of HIV infection and AIDS. Clin Microbiol Rev. 2013 Jan;26(1):2–18. DOI:10.1128/CMR.00050-12.
   PubMed Web of Science ®Google Scholar
• Caradonna L, Amati L, Magrone T, et al. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance. J Endotoxin Res. 2000;6(3):205–14.
   PubMedGoogle Scholar
• Lv T, Cao W, Li T. HIV-Related Immune activation and inflammation: current understanding and strategies. J Immunol Res. 2021;2021:7316456.
   PubMedGoogle Scholar
• Flier J, Boorsma DM, Bruynzeel DP, et al. The CXCR3 activating chemokines IP-10. Mig, and IP; 9, are expressed in allergic but not in irritant patch test reactions. J Invest Dermatol. 1999 Oct;113(4):574–8.
   PubMed Web of Science ®Google Scholar
• Hickman HD, Reynoso GV, Ngudiankama BF, et al. CXCR3 chemokine receptor enables local CD8(+) T cell migration for the destruction of virus-infected cells. Immunity. 2015 Mar 17;42(3):524–37. DOI:10.1016/j.immuni.2015.02.009.
   PubMed Web of Science ®Google Scholar
• Tokunaga R, Zhang W, Naseem M, et al. CXCL9. Cxc(L10). CXCL11/CXCR3 axis for immune activation – a target for novel cancer therapy. Cancer Treat Rev. 2018 Feb;63:40–47.
   PubMed Web of Science ®Google Scholar
• Kagi D, Ledermann B, Burki K, et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 1994 May 5;369(6475):31–7.
   PubMed Web of Science ®Google Scholar
• Dinarello CA. IL-18: A TH1-inducing, proinflammatory cytokine and new member of the IL-1 family. J Allergy Clin Immunol. 1999 Jan;103–1(Pt 1):11–24.
   Web of Science ®Google Scholar
• Yin X, Wang Z, Wu T, et al. The combination of CXCL9. CXC(L10). and CXCL11 levels during primary HIV infection predicts HIV disease progression. J Transl Med. 2019 Dec 13;17(1):417.
   PubMed Web of Science ®Google Scholar
• Kollmorgen G, Niederfellner G, Lifke A, et al. Antibody mediated CDCP1 degradation as mode of action for cancer targeted therapy. Mol Oncol. 2013 Dec;7(6):1142–51. DOI:10.1016/j.molonc.2013.08.009.
   PubMed Web of Science ®Google Scholar
• Alvarez-Diaz S, Valle N, Garcia JM, et al. Cystatin D is a candidate tumor suppressor gene induced by vitamin D in human colon cancer cells. J Clin Invest. 2009 Aug;119(8):2343–58. DOI:10.1172/JCI37205.
   PubMed Web of Science ®Google Scholar
• Wang F, Zhang C, Ge W, et al. Up-regulated CST5 inhibits bone resorption and activation of osteoclasts in rat models of osteoporosis via suppression of the NF-kappaB pathway. J Cell Mol Med. 2019 Oct;23(10):6744–6754. DOI:10.1111/jcmm.14552.
   PubMed Web of Science ®Google Scholar
• Titanji K. Beyond antibodies: B cells and the OPG/RANK-RANKL pathway in health, Non-HIV disease and HIV-induced bone loss. Front Immunol. 2017;8:1851. DOI:10.3389/fimmu.2017.01851.
   PubMed Web of Science ®Google Scholar
• Sidorenko SP, Clark EA. The dual-function CD150 receptor subfamily: the viral attraction. Nat Immunol. 2003 Jan;4(1):19–24. DOI:10.1038/ni0103-19.
   PubMed Web of Science ®Google Scholar
• Meroni L, Fusi ML, Varchetta S, et al. Altered signaling lymphocytic activation molecule (SLAM) expression in HIV infection and redirection of HIV-specific responses via SLAM triggering. Clin Immunol. 1999 Sep;92(3):276–84. DOI:10.1006/clim.1999.4747.
   PubMed Web of Science ®Google Scholar
• Massanella M, Fromentin R, Chomont N. Residual inflammation and viral reservoirs: alliance against an HIV cure. Curr Opin HIV AIDS. 2016 Mar;11(2):234–41. DOI:10.1097/COH.0000000000000230.
   PubMed Web of Science ®Google Scholar
• Swann J, Murry J, Young JA. Cytosolic sulfotransferase 1A1 regulates HIV-1 minus-strand DNA elongation in primary human monocyte-derived macrophages. Virol J. 2016 Feb 24;13:30.
   PubMed Web of Science ®Google Scholar
• Deegan S, Saveljeva S, Logue SE, et al. Deficiency in the mitochondrial apoptotic pathway reveals the toxic potential of autophagy under ER stress conditions. Autophagy. 2014;10(11):1921–36. DOI:10.4161/15548627.2014.981790.
   PubMed Web of Science ®Google Scholar
• Rothgiesser KM, Erener S, Waibel S, et al. SIRT2 regulates NF-kappaB dependent gene expression through deacetylation of p65 Lys310. J Cell Sci. 2010 Dec 15;123(24):4251–8. DOI:10.1242/jcs.073783.
   PubMed Web of Science ®Google Scholar
• Chan JK, Greene WC. NF-kappaB/Rel: agonist and antagonist roles in HIV-1 latency. Curr Opin HIV AIDS. 2011 Jan;6(1):12–8. DOI:10.1097/COH.0b013e32834124fd.
   PubMed Web of Science ®Google Scholar
• Kameoka M, Kameoka Y, Utachee P, et al. Short communication: RNA interference directed against Axin1 upregulates human immunodeficiency virus type 1 gene expression by activating the Wnt signaling pathway in HeLa-derived J111 cells. AIDS Res Hum Retroviruses. 2009 Oct;25(10):1005–11. DOI:10.1089/aid.2008.0284.
   PubMed Web of Science ®Google Scholar
• Bednash JS, Johns F, Patel N, et al. The deubiquitinase STAMBP modulates cytokine secretion through the NLRP3 inflammasome. Cell Signal. 2021 Mar;79:109859.
   PubMed Web of Science ®Google Scholar
• Zamborlini A, Usami Y, Radoshitzky SR, et al. Release of autoinhibition converts ESCRT-III components into potent inhibitors of HIV-1 budding. Proc Natl Acad Sci U S A. 2006 Dec 12;103(50):19140–5. DOI:10.1073/pnas.0603788103.
   PubMed Web of Science ®Google Scholar
• Kornbluth RS. The emerging role of CD40 ligand in HIV infection. J Leukoc Biol. 2000 Sep;68(3):373–82. DOI:10.1189/jlb.68.3.373.
   PubMed Web of Science ®Google Scholar
• Wang FX, Xu Y, Sullivan J, et al. IL-7 is a potent and proviral strain-specific inducer of latent HIV-1 cellular reservoirs of infected individuals on virally suppressive HAART. J Clin Invest. 2005 Jan;115(1):128–37. DOI:10.1172/JCI200522574.
   PubMed Web of Science ®Google Scholar
• Zhang LX, Song JW, Zhang C, et al. Dynamics of HIV reservoir decay and naive CD4 T-cell recovery between immune non-responders and complete responders on long-term antiretroviral treatment. Clin Immunol. 2021 Aug;229:108773.
   PubMed Web of Science ®Google Scholar
• Real F, Capron C, Sennepin A, et al. Platelets from HIV-infected individuals on antiretroviral drug therapy with poor CD4(+) T cell recovery can harbor replication-competent HIV despite viral suppression. Sci Transl Med. 2020 Mar 18;12:535. DOI:10.1126/scitranslmed.aat6263.
   Web of Science ®Google Scholar